{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:07:42Z","timestamp":1788754062916,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Science Foundation of Xizang Autonomous Region","award":["XZ2024ZR-ZY107(Z)"],"award-info":[{"award-number":["XZ2024ZR-ZY107(Z)"]}]},{"name":"Dalian Medical Science Research Program","award":["2023DF016"],"award-info":[{"award-number":["2023DF016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00415-026-14094-4","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T03:15:23Z","timestamp":1788750923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low-dose ticagrelor combined with aspirin for preventing early neurological deterioration in patients with high-risk non-disabling ischemic cerebrovascular events: a multicenter, prospective, randomized, open-label, clinical trial"],"prefix":"10.1007","volume":"273","author":[{"given":"Jiahui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6104-1952","authenticated-orcid":false,"given":"Xiaofei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"issue":"1","key":"14094_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1136\/jnnp-2014-308327","volume":"86","author":"P Seners","year":"2015","unstructured":"Seners P, Turc G, Oppenheim C et al (2015) Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications. J Neurol Neurosurg Psychiatry 86(1):87\u201394","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"14094_CR2","doi-asserted-by":"publisher","DOI":"10.1177\/17562864221147743","volume":"16","author":"H Liu","year":"2023","unstructured":"Liu H, Liu K, Zhang K et al (2023) Early neurological deterioration in patients with acute ischemic stroke: a prospective multicenter cohort study. Ther Adv Neurol Disord 16:17562864221147743","journal-title":"Ther Adv Neurol Disord"},{"issue":"6","key":"14094_CR3","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/neurintsurg-2022-018844","volume":"15","author":"R Bhole","year":"2023","unstructured":"Bhole R, Nouer SS, Tolley EA et al (2023) Predictors of early neurologic deterioration (END) following stroke thrombectomy. J Neurointerv Surg 15(6):584\u2013588","journal-title":"J Neurointerv Surg"},{"issue":"1","key":"14094_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.21037\/atm.2019.12.36","volume":"8","author":"P Liu","year":"2023","unstructured":"Liu P, Liu S, Feng N et al (2023) Association between neurological deterioration and outcomes in patients with stroke. Ann Transl Med 8(1):4","journal-title":"Ann Transl Med"},{"issue":"16","key":"14094_CR5","doi-asserted-by":"publisher","first-page":"e2178","DOI":"10.1212\/WNL.0000000000010603","volume":"95","author":"TH Park","year":"2020","unstructured":"Park TH, Lee JK, Park MS et al (2020) Neurologic deterioration in patients with acute ischemic stroke or transient ischemic attack. Neurology 95(16):e2178\u2013e2191","journal-title":"Neurology"},{"issue":"3","key":"14094_CR6","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ahj.2010.05.017","volume":"160","author":"Y Wang","year":"2023","unstructured":"Wang Y, Johnston SC (2023) Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event. Am Heart J 160(3):380-386.e1","journal-title":"Am Heart J"},{"issue":"16","key":"14094_CR7","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1056\/NEJMoa1412981","volume":"374","author":"P Amarenco","year":"2016","unstructured":"Amarenco P, Lavall\u00e9e PC, Labreuche J (2016) One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med 374(16):1533\u20131542","journal-title":"N Engl J Med"},{"issue":"23","key":"14094_CR8","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1056\/NEJMoa1802712","volume":"378","author":"P Amarenco","year":"2020","unstructured":"Amarenco P, Lavall\u00e9e PC, Tavares LM et al (2020) Five-year risk of stroke after TIA or minor ischemic stroke. N Engl J Med 378(23):2182\u20132190","journal-title":"N Engl J Med"},{"issue":"1","key":"14094_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1161\/STROKEAHA.114.006768","volume":"46","author":"JK Wasserman","year":"2015","unstructured":"Wasserman JK, Perry JJ, Sivilotti ML et al (2015) Computed tomography identifies patients at high risk for stroke after transient ischemic attack\/nondisabling stroke: prospective, multicenter cohort study. Stroke 46(1):114\u2013119","journal-title":"Stroke"},{"issue":"2","key":"14094_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/ene.14541","volume":"28","author":"N Boulenoir","year":"2021","unstructured":"Boulenoir N, Turc G, Henon H et al (2021) Early neurological deterioration following thrombolysis for minor stroke with isolated internal carotid artery occlusion. Eur J Neurol 28(2):479\u2013490","journal-title":"Eur J Neurol"},{"issue":"1","key":"14094_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5853\/jos.2025.05120","volume":"28","author":"JH Heo","year":"2026","unstructured":"Heo JH, Lee KO, Heo J et al (2026) Mechanism-oriented treatment of early neurologic deterioration in acute ischemic stroke. J Stroke 28(1):29\u201345","journal-title":"J Stroke"},{"issue":"1","key":"14094_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","volume":"369","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang Y, Zhao X et al (2013) Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 369(1):11\u201319","journal-title":"N Engl J Med"},{"issue":"3","key":"14094_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","volume":"379","author":"SC Johnston","year":"2018","unstructured":"Johnston SC, Easton JD, Farrant M et al (2018) Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med 379(3):215\u2013225","journal-title":"N Engl J Med"},{"issue":"1","key":"14094_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jama.2016.8662","volume":"316","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhao X, Lin J et al (2016) Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack. JAMA 316(1):70\u201378","journal-title":"JAMA"},{"issue":"28","key":"14094_CR15","doi-asserted-by":"publisher","first-page":"19900","DOI":"10.18632\/oncotarget.24945","volume":"9","author":"X Yi","year":"2018","unstructured":"Yi X, Lin J, Wang Y et al (2018) Response to clopidogrel is associated with early neurological deterioration after acute ischemic stroke. Oncotarget 9(28):19900\u201319910","journal-title":"Oncotarget"},{"issue":"19","key":"14094_CR16","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.jacc.2007.07.058","volume":"50","author":"RF Storey","year":"2007","unstructured":"Storey RF, Husted S, Harrington RA et al (2007) Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes. J Am Coll Cardiol 50(19):1852\u20131856","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"14094_CR17","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045\u20131057","journal-title":"N Engl J Med"},{"issue":"2","key":"14094_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2165\/11595930-000000000-00000","volume":"32","author":"H Li","year":"2012","unstructured":"Li H, Butler K, Yang L et al (2012) Pharmacokinetics and tolerability of single and multiple doses of ticagrelor in healthy Chinese subjects: an open-label, sequential, two-cohort, single-centre study. Clin Drug Investig 32(2):87\u201397","journal-title":"Clin Drug Investig"},{"issue":"15","key":"14094_CR19","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s40265-013-0126-z","volume":"73","author":"N Ferri","year":"2013","unstructured":"Ferri N, Corsini A, Bellosta S (2013) Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties. Drugs 73(15):1681\u20131709","journal-title":"Drugs"},{"issue":"10204","key":"14094_CR20","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0140-6736(19)31887-2","volume":"394","author":"DL Bhatt","year":"2019","unstructured":"Bhatt DL, Steg PG, Mehta SR et al (2019) Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial. Lancet 394(10204):1169\u20131180","journal-title":"Lancet"},{"key":"14094_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d3527","volume":"342","author":"SK James","year":"2011","unstructured":"James SK, Roe MT, Cannon CP et al (2011) Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient outcomes (PLATO) trial. BMJ 342:d3527","journal-title":"BMJ"},{"issue":"17","key":"14094_CR22","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/eurheartj\/ehz821","volume":"41","author":"RHM Furtado","year":"2020","unstructured":"Furtado RHM, Nicolau JC, Magnani G et al (2020) Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54. Eur Heart J 41(17):1625\u20131632","journal-title":"Eur Heart J"},{"issue":"2","key":"14094_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10557-020-06940-y","volume":"34","author":"S Ma","year":"2020","unstructured":"Ma S, Li Z, Yu P et al (2020) Efficacy and safety of potent oral P2Y12 inhibitors in medically managed ACS patients: a meta-analysis. Cardiovasc Drugs Ther 34(2):199\u2013208","journal-title":"Cardiovasc Drugs Ther"},{"issue":"14","key":"14094_CR24","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2021","unstructured":"Collet JP, Thiele H, Barbato E et al (2021) 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 42(14):1289\u20131367","journal-title":"Eur Heart J"},{"issue":"27","key":"14094_CR25","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1056\/NEJMoa2111749","volume":"385","author":"Y Wang","year":"2021","unstructured":"Wang Y, Meng X, Wang A et al (2021) Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA. N Engl J Med 385(27):2520\u20132530","journal-title":"N Engl J Med"},{"issue":"3","key":"14094_CR26","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/ana.26287","volume":"91","author":"A Wang","year":"2022","unstructured":"Wang A, Meng X, Tian X et al (2022) Bleeding risk of dual antiplatelet therapy after minor stroke or transient ischemic attack. Ann Neurol 91(3):380\u2013388","journal-title":"Ann Neurol"},{"issue":"19","key":"14094_CR27","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","volume":"372","author":"MP Bonaca","year":"2015","unstructured":"Bonaca MP, Bhatt DL, Cohen M et al (2015) Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med 372(19):1791\u20131800","journal-title":"N Engl J Med"},{"issue":"1","key":"14094_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1136\/jnis-2024-022536","volume":"18","author":"A Mehta","year":"2025","unstructured":"Mehta A, Reddi P, Bose SJ et al (2025) Lower ticagrelor dosing in the dual antiplatelet regimen for neurointerventional procedures. J Neurointerv Surg 18(1):271\u2013277","journal-title":"J Neurointerv Surg"},{"issue":"8","key":"14094_CR29","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/jamaneurol.2022.1457","volume":"79","author":"Y Pan","year":"2022","unstructured":"Pan Y, Meng X, Jin A et al (2022) Time course for benefit and risk with ticagrelor and aspirin in individuals with acute ischemic stroke or transient ischemic attack who carry CYP2C19 loss-of-function alleles: a secondary analysis of the CHANCE-2 randomized clinical trial. JAMA Neurol 79(8):739\u2013745","journal-title":"JAMA Neurol"},{"issue":"3","key":"14094_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa1916870","volume":"383","author":"SC Johnston","year":"2020","unstructured":"Johnston SC, Amarenco P, Denison H et al (2020) Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA. N Engl J Med 383(3):207\u2013217","journal-title":"N Engl J Med"},{"issue":"12","key":"14094_CR31","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T et al (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 50(12):e344\u2013e418","journal-title":"Stroke"},{"issue":"3","key":"14094_CR32","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/svn-2019-000321","volume":"5","author":"T Zhang","year":"2020","unstructured":"Zhang T, Zhao J, Li X et al (2020) Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of stroke rehabilitation. Stroke Vasc Neurol 5(3):250\u2013259","journal-title":"Stroke Vasc Neurol"},{"issue":"11","key":"14094_CR33","first-page":"2220","volume":"25","author":"P Lyden","year":"1994","unstructured":"Lyden P, Brott T, Tilley B et al (1994) Improved reliability of the NIH stroke scale using video training. NINDS TPA Stroke Study Group Stroke 25(11):2220\u20132226","journal-title":"NINDS TPA Stroke Study Group Stroke"},{"issue":"5","key":"14094_CR34","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC van Swieten","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC et al (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19(5):604\u2013607","journal-title":"Stroke"},{"issue":"1","key":"14094_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24(1):35\u201341","journal-title":"Stroke"},{"key":"14094_CR36","doi-asserted-by":"crossref","unstructured":"GUSTO investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 329(10): 673\u201382","DOI":"10.1056\/NEJM199309023291001"},{"issue":"14\u201315","key":"14094_CR37","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1080\/14656566.2025.2576607","volume":"26","author":"M Galli","year":"2025","unstructured":"Galli M, Simeone B, Gragnano F et al (2025) Optimizing selection of P2Y(12) inhibiting therapy: clopidogrel, prasugrel or ticagrelor. Expert Opin Pharmacother 26(14\u201315):1565\u20131581","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"14094_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12959-023-00559-3","volume":"22","author":"P Wei","year":"2024","unstructured":"Wei P, Wang X, Fu Q et al (2024) Progress in the clinical effects and adverse reactions of ticagrelor. Thromb J 22(1):8","journal-title":"Thromb J"},{"issue":"6","key":"14094_CR39","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/jcbfm.2014.45","volume":"34","author":"P Gelosa","year":"2025","unstructured":"Gelosa P, Lecca D, Fumagalli M et al (2025) Microglia is a key player in the reduction of stroke damage promoted by the new antithrombotic agent ticagrelor. J Cereb Blood Flow Metab 34(6):979\u2013988","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"14094_CR40","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00228-022-03348-5","volume":"78","author":"J Shen","year":"2022","unstructured":"Shen J, Liu G, Wu G et al (2022) Ticagrelor versus clopidogrel in reducing inflammatory cell infiltration of thrombus aspirated in patients with ST-elevation myocardial infarction. Eur J Clin Pharmacol 78(9):1391\u20131398","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"14094_CR41","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/jamaneurol.2024.0146","volume":"81","author":"HS Chen","year":"2024","unstructured":"Chen HS, Cui Y, Wang XH et al (2024) Clopidogrel plus aspirin vs aspirin alone in patients with acute mild to moderate stroke: the ATAMIS randomized clinical trial. JAMA Neurol 81(5):450\u2013460","journal-title":"JAMA Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14094-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14094-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14094-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T03:15:31Z","timestamp":1788750931000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-14094-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["14094"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-14094-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"30 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests in this study.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Dalian Medical University (PJ-KS-KY-2023-03(X)), and the study adhered to the principles of the Declaration of Helsinki and the guidelines for Good Clinical Practice.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Every patient or their legal representatives provided written informed consent before participation.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"568"}}